P-glycoprotein multidrug resistance and cancer
- 1 October 1996
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1288 (2), F37-F54
- https://doi.org/10.1016/0304-419x(96)00022-4
Abstract
No abstract availableKeywords
This publication has 253 references indexed in Scilit:
- Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancersEuropean Journal Of Cancer, 1994
- Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patientsEuropean Journal Of Cancer, 1993
- Overcoming Multidrug Resistance in Human Tumor Cells Using Free and Liposomally Encapsulated Antisense OligodeoxynucleotidesBiochemical and Biophysical Research Communications, 1993
- ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- Flowcytometric analysis of multidrug-resistance-associated antigen (P-Glycoprotein) and DNA ploidy in human colon cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Intermittent high-dose tamoxifen as a potential modifier of multidrug resistanceEuropean Journal Of Cancer, 1992
- Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristineEuropean Journal of Cancer and Clinical Oncology, 1991
- MDR1 gene expression and prognostic factors in primary breast carcinomasEuropean Journal of Cancer and Clinical Oncology, 1991
- Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cellsBiochemical and Biophysical Research Communications, 1990
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986